For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...

What does the new Pluvicto approval mean for prostate cancer? Here is who may qualify, how it works, benefits, side effects and treatment details.

Results of the NRG Oncology NRG-GU005 clinical study comparing stereotactic body radiation therapy (SBRT) with moderately ...

Salvage radiation given over 26 sessions kept prostate cancer in check as well as the conventional schedule did, according to ...

Prostate cancer is Australia's most commonly diagnosed cancer. One in six men will be diagnosed by the time they turn 85. Cancers are abnormal groups of cells that grow uncontrollably and start ...

Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery ...

From radiopharmaceuticals to hypofractionated radiation therapy, one expert explained the current landscape of radiation treatments for prostate cancer. Radiopharmaceuticals, defined by the National ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...

Learn about medications, surgery, radiation, exercise, and other therapies and strategies for symptom relief from advanced ...

Tumor DNA profiling could be used to identify which men with metastatic prostate cancer need aggressive treatment and those who may benefit from de-escalation.A model, trained and tested on nearly ...

Mack Roach, III, MD, FASTRO, has been chosen by the American Society for Radiation Oncology (ASTRO) to receive its 2024 Gold Medal Award. Roach is being recognized with ASTRO’s highest honor for his ...